Clinical Trials

NCT05572684 | TERMINATED | PHASE1/PHASE2
97 participants

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2022-10-06
Completion:
2025-04-30
Conditions
  • Advanced or Metastatic Solid Tumors
  • Microsatellite Instability Low
  • Microsatellite Instability High
  • Microsatellite Stable
  • Ovarian Cancer
  • Gastric Cancer
  • Colo-rectal Cancer
  • Esophageal Cancer
  • Endometrial Cancer
  • Head Neck Cancer
  • Cervical Cancer
  • Lung Cancer
Interventions
  • DRUG
NCT05564390 | RECRUITING | PHASE2
2000 participants

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2024-06-18
Completion:
2029-05-15
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Acute Myeloid Leukemia, Myelodysplasia-Related
  • Myelodysplastic Syndrome
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT05554406 | RECRUITING | PHASE2
335 participants

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2024-09-25
Completion:
2027-03-31
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Acute Myeloid Leukemia, Myelodysplasia-Related
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05543200 | RECRUITING
7500 participants

BPH Global Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2023-03-13
Completion:
2027-12-31
Conditions
  • Benign Prostatic Hyperplasia
  • Lower Urinary Tract Symptoms
No Results Yet
NCT05486234 | RECRUITING | NA
52 participants

CARS: Cannabis and Alcohol Reduction Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2023-01-25
Completion:
2026-09-30
Conditions
  • Cannabis Use
  • Alcohol Use, Unspecified
  • Substance Use
  • Substance Use Disorders
Interventions
  • BEHAVIORAL
No Results Yet
NCT05357833 | COMPLETED | EARLY_PHASE1
11 participants

Novel Imaging Markers in SPMS

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2022-06-01
Completion:
2023-09-01
Conditions
  • Secondary Progressive Multiple Sclerosis
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
No Results Yet
NCT05256225 | RECRUITING | PHASE3
360 participants

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2022-11-16
Completion:
2027-10-31
Conditions
  • Endometrial Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Dedifferentiated Carcinoma
  • Endometrial Endometrioid Adenocarcinoma
  • Endometrial Mixed Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Endometrial Undifferentiated Carcinoma
  • Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page